GlassScriptPhysician profile
Christopher R Williams
NPI 1972578136
$2,062.23
in general payments reported to CMS, 2019-2025
21 companies · $243 in 2025
The $243 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,127 · 2020: $271 · 2021: $228 · 2022: $38.25 · 2023: $18.47 · 2024: $137 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $398.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $231.08 | 2019-2024 | Cook |
| Ferring Pharmaceuticals INC. | $175.32 | 2024-2025 | Adstiladrin |
| Janssen Biotech, INC. | $146.00 | 2019 | |
| Karl Storz Endoscopy-America | $141.43 | 2019 | |
| Janssen Pharmaceuticals, INC | $125.00 | 2019 | |
| Conmed Corporation | $122.73 | 2019 | |
| Novo Nordisk INC | $114.57 | 2019 | |
| Horizon Therapeutics Plc | $111.91 | 2020 | |
| Coloplast Corp | $111.91 | 2020 | |
| Boston Scientific Corporation | $108.60 | 2019 | |
| Astellas Pharma US INC | $105.26 | 2019-2021 | |
| Telix Pharmaceuticals | $103.50 | 2025 | Illuccix |
| Tolmar Pharmaceuticals, INC. | $103.11 | 2020-2021 | |
| C. R. Bard, INC. & Subsidiaries | $82.11 | 2019 | |
| Merck Sharp & Dohme LLC | $74.72 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $74.21 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $49.65 | 2021 | |
| Profound Medical Corp. | $24.40 | 2021 | |
| Progenics Pharmaceuticals, INC. | $23.81 | 2022 | |
| Sumitomo Pharma America, INC. | $18.47 | 2023 | Gemtesa |
| Abc Home Medical Supply, INC. | $14.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.